The tremendous diversity of genetic alterations in cancer samples leads a governmental senior advisor to look for shared pathways among all tumors for a possible cure.
Melanoma rate shave been rising, and while genetic tests are available for high-risk patients, a family history is a better way to identify patients who need potentially life-saving surveillance.
Molecular diagnostics tests could cost Americans $15 billion to $25 billion by the end of the next decade. Physicians believe the tests are warranted, although they're skeptical about costs and their ability to interpret them properly for patients.
Despite the 90% heritability of autism, suggesting a very strong genetic component to its etiology, zeroing in on the genetic underpinnings of this disorder has been very challenging.
There is ongoing debate whether genomics will revolutionize medicine or if it's simply a pipe dream. ... Those in primary care who have questioned whether genomics is having much of an effect should take notice of this case.